About Zhejiang Jingxin Pharmaceutical Co., Ltd
Zhejiang Jingxin Pharmaceutical, founded in 1990 and headquartered in Xinchang, Zhejiang Province, is a listed pharmaceutical company integrating research and development, manufacturing and marketing. The sources consulted rank it among China's leading chemical pharmaceutical enterprises, with a strong position in quinolone APIs.
Its portfolio combines active ingredients and finished dosage forms in tablets, capsules and injections. Its APIs include ciprofloxacin and its salts, levofloxacin, enrofloxacin, statins such as simvastatin and rosuvastatin, ticagrelor, rivaroxaban, apixaban, levetiracetam, sertraline and other active ingredients for areas such as antibiotics, cardiovascular, antidiabetic and antiepileptic medicines.
Jingxin sells its products in China and in international markets across Asia, Latin America and Europe, and complements its pharmaceutical activity with medical devices and Chinese herbal products. Its integrated model, from API to finished medicine, defines its position as a manufacturer of generics and pharmaceutical raw materials.
Its portfolio combines active ingredients and finished dosage forms in tablets, capsules and injections. Its APIs include ciprofloxacin and its salts, levofloxacin, enrofloxacin, statins such as simvastatin and rosuvastatin, ticagrelor, rivaroxaban, apixaban, levetiracetam, sertraline and other active ingredients for areas such as antibiotics, cardiovascular, antidiabetic and antiepileptic medicines.
Jingxin sells its products in China and in international markets across Asia, Latin America and Europe, and complements its pharmaceutical activity with medical devices and Chinese herbal products. Its integrated model, from API to finished medicine, defines its position as a manufacturer of generics and pharmaceutical raw materials.